Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07607275 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 7 of 17 entries
    • Site details revised at 6 of 16 sites
  2. Recruitment opened
    • Eligibility criteria revised
    • Site details revised at 16 of 16 sites
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Yufeng Ningxin, a traditional Chinese medicine, has demonstrated potential antihypertensive effects in animal studies and small clinical trials, but has not yet been rigorously evaluated in large randomized clinical trials. Here, the investigators conducted a double-blind, randomized controlled trial to assess the efficacy and safety of Yufeng Ningxin tablets in patients with hypertension.
Trial Details
NCT Number NCT07607275
Lead Sponsor Beijing Anzhen Hospital
Conditions
(from sponsor)		 Hypertension, Essential (Primary) Hypertension
Related terms Essential Hypertension, Hypertension
Enrollment 350 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov